Illumina Inc ILMN

NAS: ILMN | ISIN: US4523271090 30/12/2025

132,75 USD (-1,29%)

(-1,29%) 30/12/2025

Grafiek Illumina Inc

Grafiek Illumina Inc

1 dag1d -1,29%
1 week1w -1,90%
1 maand1m 3,13%
3 maanden3m 39,78%
6 maanden6m 39,14%
1 jaar1j -0,66%
5 jaar5j -64,12%

Illumina Inc in het nieuws

Toon enkel gratis nieuws

16 december 2025 · Illumina To Webcast Upcoming Investor Conference · Persbericht

14 december 2025 · /C O R R E C T I O N -- MyOme, Inc/ · Persbericht

11 december 2025 · Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually · Persbericht

12 november 2025 · Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study · Persbericht

11 november 2025 · Illumina To Webcast Upcoming Investor Conference · Persbericht

10 november 2025 · Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks · Persbericht

5 november 2025 · Illumina Responds to Positive Updates from Chinese Ministry of Commerce · Persbericht

30 oktober 2025 · Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 · Persbericht

15 oktober 2025 · Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights · Persbericht

15 oktober 2025 · Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot · Persbericht

Profiel Illumina Inc

Gezondheidstechnologie

Productie van analytische laboratoriuminstrumenten

Website: www.illumina.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe